Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference23 articles.
1. Low-dose mifepristone for uterine leiomyomas;Eisinger;Obstet Gynecol,2003
2. Effect of mifepristone for symptomatic leiomyomas on quality of life and uterine size: a randomized controlled trial;Fiscella;Obstet Gynecol,2006
3. Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial;Bagaria;Aust NZ J Obstet Gynecol,2009
4. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomas;Eisinger;Eur J Obstet Gynecol Reprod Biol,2009
5. Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial;Carbonell Esteve;Obstet Gynecol,2008
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predicting Progestin Therapy Response With PTEN, PAX2, and β-Catenin in Patients With Endometrioid Precancer;International Journal of Gynecological Pathology;2024-01-31
2. Unveiling Residual Diseases of Endometrial Precancer/Cancer After Progestin Therapy;Gynecologic and Obstetric Pathology;2024
3. Exogenous Hormone-Induced Endometrial Changes;Gynecologic and Obstetric Pathology;2024
4. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms;JAMA Network Open;2023-06-12
5. Long-term use of ultra-low-dose mifepristone for uterine leiomyoma control and safety discussion: A case report;Medicine;2022-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3